share_log

わかもと製薬株式会社:緑内障・高眼圧症治療剤「WP-1303」の開発中止に関するお知らせ

Wakamoto Pharmaceutical Co Ltd: Notice on the suspension of the development of the therapeutic agent "WP-1303" for glaucoma hypertension

JPX ·  Sep 9, 2019 18:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more